Visit Contract Pharma
at Booth #1921

Financial Report: West Pharmaceutical Services

10.25.18

Revenues up 8% in the quarter led by growth in the Pharma Market Unit

West Pharmaceutical Services
3Q Revenues: $431.7 million (+8%)
3Q Earnings: $55.2 million (+8%)
YTD Revenues: $1.3 billion (+9%)
YTD Earnings: $154.9 million (+3%)
Comments: Proprietary Products segment sales were $325.2 million in the quarter, up 5% led by double-digit growth in the Pharma Market Unit. Contract manufactured product sales were $106.7 million, up 19% driven by continued demand for diabetes-related diagnostic and drug delivery devices. Biologics sales were impacted by a decline in self-injection delivery device sales associated with lower than expected commercial sales of the underlying drug product.